BACKGROUND: It has recently been shown that vitamin D deficiency can increase asthma development and severity and that variations in vitamin D receptor genes are associated with asthma susceptibility. OBJECTIVE: We sought to find genetic factors that might interact with vitamin D levels to affect the risk of asthma exacerbation. METHODS: We conducted a genome-wide study of gene-vitamin D interaction on asthma exacerbations using population-based and family-based approaches on 403 subjects and trios from the Childhood Asthma Management Program. Twenty-three polymorphisms with significant interactions were studied in a replication analysis in 584 children from a Costa Rican cohort. RESULTS: We identified 3 common variants in the class I MHC-restricted T cell-associated molecule gene (CRTAM) that were associated with an increased rate of asthma exacerbations based on the presence of a low circulating vitamin D level. These results were replicated in a second independent population (unadjusted combined interaction, P = .00028-.00097; combined odds ratio, 3.28-5.38). One variant, rs2272094, is a nonsynonymous coding polymorphism of CRTAM. Functional studies on cell lines confirmed the interaction of vitamin D and rs2272094 on CRTAM expression. CRTAM is highly expressed in activated human CD8(+) and natural killer T cells, both of which have been implicated in asthmatic patients. CONCLUSION: The findings highlight an important gene-environment interaction that elucidates the role of vitamin D and CD8(+) and natural killer T cells in asthma exacerbation in a genome-wide gene-environment interaction study that has been replicated in an independent population. The results suggest the potential importance of maintaining adequate vitamin D levels in subsets of high-risk asthmatic patients.
RCT Entities:
BACKGROUND: It has recently been shown that vitamin Ddeficiency can increase asthma development and severity and that variations in vitamin D receptor genes are associated with asthma susceptibility. OBJECTIVE: We sought to find genetic factors that might interact with vitamin D levels to affect the risk of asthma exacerbation. METHODS: We conducted a genome-wide study of gene-vitamin D interaction on asthma exacerbations using population-based and family-based approaches on 403 subjects and trios from the Childhood Asthma Management Program. Twenty-three polymorphisms with significant interactions were studied in a replication analysis in 584 children from a Costa Rican cohort. RESULTS: We identified 3 common variants in the class I MHC-restricted T cell-associated molecule gene (CRTAM) that were associated with an increased rate of asthma exacerbations based on the presence of a low circulating vitamin D level. These results were replicated in a second independent population (unadjusted combined interaction, P = .00028-.00097; combined odds ratio, 3.28-5.38). One variant, rs2272094, is a nonsynonymous coding polymorphism of CRTAM. Functional studies on cell lines confirmed the interaction of vitamin D and rs2272094 on CRTAM expression. CRTAM is highly expressed in activated humanCD8(+) and natural killer T cells, both of which have been implicated in asthmatic patients. CONCLUSION: The findings highlight an important gene-environment interaction that elucidates the role of vitamin D and CD8(+) and natural killer T cells in asthma exacerbation in a genome-wide gene-environment interaction study that has been replicated in an independent population. The results suggest the potential importance of maintaining adequate vitamin D levels in subsets of high-risk asthmatic patients.
Authors: Audrey H Poon; Catherine Laprise; Mathieu Lemire; Alexandre Montpetit; Donna Sinnett; Erwin Schurr; Thomas J Hudson Journal: Am J Respir Crit Care Med Date: 2004-07-28 Impact factor: 21.405
Authors: I Chinellato; M Piazza; M Sandri; D G Peroni; F Cardinale; G L Piacentini; A L Boner Journal: Eur Respir J Date: 2010-11-11 Impact factor: 16.671
Authors: Edmund J S Sonuga-Barke; Jessica Lasky-Su; Benjamin M Neale; Robert Oades; Wai Chen; Barbara Franke; Jan Buitelaar; Tobias Banaschewski; Richard Ebstein; Michael Gill; Richard Anney; Ana Miranda; Fernando Mulas; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans Christoph Steinhausen; Margaret Thompson; Philip Asherson; Stephen V Faraone Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2008-12-05 Impact factor: 3.568
Authors: Carlos A Camargo; Sheryl L Rifas-Shiman; Augusto A Litonjua; Janet W Rich-Edwards; Scott T Weiss; Diane R Gold; Ken Kleinman; Matthew W Gillman Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Rebecca E Slager; Gregory A Hawkins; Xingnan Li; Dirkje S Postma; Deborah A Meyers; Eugene R Bleecker Journal: Clin Chest Med Date: 2012-07-07 Impact factor: 2.878
Authors: Michael J McGeachie; Ann C Wu; Sze Man Tse; George L Clemmer; Joanne Sordillo; Blanca E Himes; Jessica Lasky-Su; Robert P Chase; Fernando D Martinez; Peter Weeke; Christian M Shaffer; Hua Xu; Josh C Denny; Dan M Roden; Reynold A Panettieri; Benjamin A Raby; Scott T Weiss; Kelan G Tantisira Journal: J Allergy Clin Immunol Date: 2015-06-12 Impact factor: 10.793
Authors: Yamini V Virkud; Rachel S Kelly; Damien C Croteau-Chonka; Juan C Celedón; Amber Dahlin; Lydiana Avila; Benjamin A Raby; Scott T Weiss; Jessica A Lasky-Su Journal: Clin Exp Allergy Date: 2018-11-21 Impact factor: 5.018
Authors: Rachel S Kelly; Bo L Chawes; Kevin Blighe; Yamini V Virkud; Damien C Croteau-Chonka; Michael J McGeachie; Clary B Clish; Kevin Bullock; Juan C Celedón; Scott T Weiss; Jessica A Lasky-Su Journal: Chest Date: 2018-06-13 Impact factor: 9.410